Amgen Research (Munich) GmbH vs. Regeneron Pharmaceuticals, Inc. - EP3611193
EPO OPPOSITION Opposition
Status:
Opposition Filed
Publication Number
EP3611193
Filing Date
2026-08-26
Applicant / Office
BINDING MOLECULES FOR BCMA AND CD3